Tech Company Financing Transactions

Bryn Pharma Funding Round

Bryn Pharma closed a $17.5 million financing round on 10/25/2019. Backers included private investors.

Transaction Overview

Company Name
Announced On
10/25/2019
Transaction Type
Venture Equity
Amount
$17,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for U.S. approval and to preparation for commercialization of BRYN-NDS1C, its bidose epinephrine nasal spray.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7101 Millstone Ridge Ct.
Raleigh, NC 27614
USA
Email Address
Overview
Bryn Pharma was founded by patients who are personally affected by anaphylaxis. The concerns of patients and caregivers like us have informed our approach. Our experience has fueled our drive to find A Better Way. We are creating a practical solution to help our community better manage their daily lives with severe allergies.
Profile
Bryn Pharma LinkedIn Company Profile
Social Media
Bryn Pharma Company Twitter Account
Company News
Bryn Pharma News
Facebook
Bryn Pharma on Facebook
YouTube
Bryn Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Dworaczyk
  David Dworaczyk LinkedIn Profile  David Dworaczyk Twitter Account  David Dworaczyk News  David Dworaczyk on Facebook
Chief Financial Officer
Dale Sander
  Dale Sander LinkedIn Profile  Dale Sander Twitter Account  Dale Sander News  Dale Sander on Facebook
Co-Founder
Michelle Lobel
  Michelle Lobel LinkedIn Profile  Michelle Lobel Twitter Account  Michelle Lobel News  Michelle Lobel on Facebook
President
Steven Hartman
  Steven Hartman LinkedIn Profile  Steven Hartman Twitter Account  Steven Hartman News  Steven Hartman on Facebook
VP - Bus. Development
Stephen Beckman
  Stephen Beckman LinkedIn Profile  Stephen Beckman Twitter Account  Stephen Beckman News  Stephen Beckman on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/25/2019: Modern Animal venture capital transaction
Next: 10/25/2019: Gallant venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary